(Q40222772)

18 September 2017

title

The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine (English)

1 reference

18 September 2017

Milner RJ

1

1 reference

18 September 2017

Salute M

2

1 reference

18 September 2017

Crawford C

3

1 reference

18 September 2017

Abbot JR

4

1 reference

18 September 2017

Farese J

5

1 reference

18 September 2017

publication date

5 October 2006

1 reference

Veterinary Immunology and Immunopathology

18 September 2017

published in

1 reference

18 September 2017

volume

114

1 reference

18 September 2017

issue

3-4

1 reference

18 September 2017

page(s)

273-284

1 reference

Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Enhancing antimelanoma immune responses through apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Biological study of R24 mouse monoclonal antibody in patients undergoing thoracotomy for pulmonary metastases from soft tissue sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Self- and nonself-recognition by C-type lectins on dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

A new colorimetric method for measuring cell-mediated cytotoxicity in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

GD3 expression by cultured human tumor cells of neuroectodermal origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Construction of immunogenic GD3-conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Toll-like receptors as adjuvant receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barré and Fisher's syndromes: their association with cranial nerve dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Biological response modifiers: interferons, interleukins, recombinant products, liposomal products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Vaccine therapy in the treatment of melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Glycosphingolipids in the cerebrospinal fluid of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Le(a), sialyl Le(x), GD3 and GM2) better than soluble lysate cancer vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Quantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Human antiganglioside autoantibodies: validation of ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Induction of apoptosis by canine natural killer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Immunogenicity of melanoma-associated gangliosides in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

AIDP and CIDP having specific antibodies to the carbohydrate epitope (-NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glc-) of gangliosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Cross-presentation of disialoganglioside GD3 to natural killer T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.08.012

10.1016/J.VETIMM.2006.08.012

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference